Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126201371 | 12620137 | 1 | I | 20160619 | 20160708 | 20160803 | 20160803 | EXP | GB-MHRA-EYC 00141928 | GB-TEVA-676638ACC | TEVA | 65.00 | YR | M | Y | 70.00000 | KG | 20160804 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126201371 | 12620137 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | 1000 MILLIGRAM DAILY; | 3000 | MG | Y | U | N/A | 65154 | 500 | MG | BID | ||
| 126201371 | 12620137 | 2 | C | RENACET | 2 | 2850 MILLIGRAM DAILY; | 0 | 950 | MG | TID | |||||||||
| 126201371 | 12620137 | 3 | C | ALFACALCIDOL | ALFACALCIDOL | 1 | .5 IU (INTERNATIONAL UNIT) DAILY; | 0 | .5 | IU | QD | ||||||||
| 126201371 | 12620137 | 4 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | 30 MILLIGRAM DAILY; | 0 | 30 | MG | QD | ||||||||
| 126201371 | 12620137 | 5 | C | DILTIAZEM. | DILTIAZEM | 1 | 180 MILLIGRAM DAILY; | 0 | 180 | MG | QD | ||||||||
| 126201371 | 12620137 | 6 | C | GLICLAZIDE | GLICLAZIDE | 1 | 40 MILLIGRAM DAILY; | 0 | 40 | MG | QD | ||||||||
| 126201371 | 12620137 | 7 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | 1200 MILLIGRAM DAILY; | 0 | 400 | MG | TID | ||||||||
| 126201371 | 12620137 | 8 | C | ASPIRIN. | ASPIRIN | 1 | 75 MILLIGRAM DAILY; | 0 | 75 | MG | QD | ||||||||
| 126201371 | 12620137 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | PATIENT STOPPED TAKING | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126201371 | 12620137 | 1 | Helicobacter infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126201371 | 12620137 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126201371 | 12620137 | Abdominal distension | |
| 126201371 | 12620137 | Ageusia | |
| 126201371 | 12620137 | Amnesia | |
| 126201371 | 12620137 | Anxiety | |
| 126201371 | 12620137 | Diarrhoea | |
| 126201371 | 12620137 | Dizziness | |
| 126201371 | 12620137 | Drug prescribing error | |
| 126201371 | 12620137 | Flatulence | |
| 126201371 | 12620137 | Hallucination | |
| 126201371 | 12620137 | Insomnia | |
| 126201371 | 12620137 | Logorrhoea | |
| 126201371 | 12620137 | Mydriasis | |
| 126201371 | 12620137 | Tinnitus | |
| 126201371 | 12620137 | Tongue discolouration | |
| 126201371 | 12620137 | Tooth discolouration | |
| 126201371 | 12620137 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126201371 | 12620137 | 1 | 20160616 | 20160620 | 0 |